Antitumor immunity could be enhanced by TIM-3 antibodies, since T helper 1 (TH1) cell responses could be inhibited by TIM-3, the ligand of which is galectin 9 (which itself enjoys an upregulation in several cancer types, such as breast cancer). The gene discussed is HAVCR2; the disease is cancer.